Electrophysiologic effects of endothelin receptor-A blockade in patients with coronary artery disease

Journal of Interventional Cardiac Electrophysiology

Volumn 8, Issue 3, 2003, Pages 173-179

  Kolettis, Theofilos M ^a   Kyriakides, Zenon S ^b   Leftheriotis, Dionyssios ^b   Papalambrou, Anastasios ^b   Kremastinos, Dimitrios Th ^b   Webb, David J ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Electrophysiology; Endothelin; QT dispersion; QT interval

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG INFUSION; DRUG MECHANISM; FEMALE; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART REPOLARIZATION; HUMAN; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; MALE; OPEN STUDY; PRIORITY JOURNAL; QT INTERVAL; REFRACTORY PERIOD;

AGED; ATRIOVENTRICULAR NODE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; SINOATRIAL NODE; SODIUM CHLORIDE;

EID: 0038726165     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023961004016     Document Type: Article

References (25)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Levin ER. Endothelins. N Engl J Med 1995;333:356-363.
3. Ishikawa T, Yanagisawa M, Kimura S, et al. Positive inotrope action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 1988;255:H970-H973.
4. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertension 1988;16:1081-1098.
5. Han S-P, Knuepfer MM, Trapani AJ, et al. Cardiac and vascular actions of sarafotoxin S6b and endothelin-1. Life Sciences 1990;46:767-775.
6. Ishikawa Y, Yanagisawa M, Kimura S, et al. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Eur J Physiol 1988;413:108-110.
7. Yorikane R, Koike H. The arrhythmogenic action of endothelin in rats. Jpn J Pharmacol 1990;53:259-263.
8. Spratt JCS, Goddard J, Patel N, et al. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 2001;134:648-654.
9. Cowburn PJ, Cleland JGF, McArthur JD, et al. Short-term haemodynamic effects of BQ-123, a selective endothelin ETA-receptor antagonist, in chronic heart failure. Lancet 1998;352:201-202.
10. Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
11. Sutsch G, Kiowski W, Yan X-W, et al. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 1998;98:2262-2268.
12. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-854.
13. Kyriakides ZS, Kremastinos DT, Kolettis TM, et al. Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Circulation 2000;102:1937-1943.
14. Berrazueta JR, Bhagat K, Vallance P, et al. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm. Br J Clin Pharmacol 1997;44:569-571.
15. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-370.
16. Higham PD, Campbell RWF. QT dispersion. Br Heart J 1994;71:508-510.
17. Zareba W, Moss AJ, Cessie SI. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994;74:550-553.
18. Fattori R, Piva R, Schicchi F, et al. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison. Eur J Radiol 1994;18 Suppl 1:S61-S66.
19. Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev 1992;12:391-421.
20. Aramori I, Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected chinese hamster ovary cells. J Biol Chem 1992;267;12468-12474.
21. Ono K, Tsujimoto G, Sakamoto A, et al. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 1994;370:301-304.
22. Yorikane R, Koike H, Miyake S. Electrophysiological effects of endothelin-1 on canine myocardial cells. J Cardiovasc Pharmacology 1991;17(suppl 7):S159-S162.
23. Szokodi I, Horkay F, Merkely B, et al. Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs. Cardiovasc Res 1998;38:356-364.
24. A receptor antagonist BQ-123, on ischaemic arrhythmias in anaesthetized rats. J Cardiovasc Pharmacol 1995;25:634-642.
25. Sharif I, Kane KA, Wainwright CL. Endothelin and ischemic arrhythmias-antiarrhythmic or arrhythmogenic? Cardiovasc Res 1998;39:625-632.